Gossamer Bio (GOSS) EV/EBITDA US GAAP (year values) |
|||||||||
| 2021 | 2022 | 2023 | 2024 | 2025 | LTM ? | CAGR 5 years ? | |||
| EV/EBITDA | ? | -3.37 | -0.73 | -0.75 | -2.83 | -4.77 | -0.88 | ||
| Changes by years, y/y, % | +137% | -78% | +3% | +276% | +69% | +27.3% | |||
Gossamer Bio. EV/EBITDA
Gossamer Bio. EV/EBITDA, changes, %
Gossamer Bio (GOSS) EV/EBITDA US GAAP (quarter values) |
||||||||
| 2025Q1 | 2025Q2 | 2025Q3 | 2025Q4 | 2026Q1 | LTM ? | |||
| EV/EBITDA | ? | -5.44 | -2.10 | -4.26 | -4.84 | -1.06 | -0.88 | |
| Changes by years, y/y, % | +266% | +160% | +123% | +71% | -80% | |||
| Changes by quarters, q/q, % | +92% | -62% | +103% | +13% | -78% | |||